These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22958492)

  • 1. The renin-angiotensin-aldosterone system in podocytes.
    Wennmann DO; Hsu HH; Pavenstädt H
    Semin Nephrol; 2012 Jul; 32(4):377-84. PubMed ID: 22958492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin induces apoptosis in podocytes through a receptor-mediated, angiotensin II-independent mechanism.
    Yuan H; Ren ZL; Hu FQ; Liang W; Ding GH
    Am J Med Sci; 2012 Dec; 344(6):441-6. PubMed ID: 22874619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (Pro)renin receptor contributes to pregnancy-induced sodium-water retention in rats via activation of intrarenal RAAS and α-ENaC.
    Fu Z; Hu J; Zhou L; Chen Y; Deng M; Liu X; Su J; Lu A; Fu X; Yang T
    Am J Physiol Renal Physiol; 2019 Mar; 316(3):F530-F538. PubMed ID: 30379098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unveiling Angiotensin II and Losartan-Induced Gene Regulatory Networks Using Human Urine-Derived Podocytes.
    Thimm C; Erichsen L; Wruck W; Adjaye J
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined blockade of angiotensin II and prorenin receptors ameliorates podocytic apoptosis induced by IgA-activated mesangial cells.
    Leung JC; Chan LY; Saleem MA; Mathieson PW; Tang SC; Lai KN
    Apoptosis; 2015 Jul; 20(7):907-20. PubMed ID: 25808596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes.
    Sakoda M; Ichihara A; Kurauchi-Mito A; Narita T; Kinouchi K; Murohashi-Bokuda K; Saleem MA; Nishiyama A; Suzuki F; Itoh H
    Am J Hypertens; 2010 May; 23(5):575-80. PubMed ID: 20075844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 rat.
    Whaley-Connell A; Habibi J; Wei Y; Gutweiler A; Jellison J; Wiedmeyer CE; Ferrario CM; Sowers JR
    Am J Physiol Renal Physiol; 2009 May; 296(5):F1013-22. PubMed ID: 19261739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent regulation of renin-angiotensin-aldosterone system in the kidney.
    Nishiyama A; Kobori H
    Clin Exp Nephrol; 2018 Dec; 22(6):1231-1239. PubMed ID: 29600408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of a local renin angiotensin system in podocytes by glucose.
    Durvasula RV; Shankland SJ
    Am J Physiol Renal Physiol; 2008 Apr; 294(4):F830-9. PubMed ID: 18216149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-Angiotensin-Aldosterone System Inhibition Increases Podocyte Derivation from Cells of Renin Lineage.
    Lichtnekert J; Kaverina NV; Eng DG; Gross KW; Kutz JN; Pippin JW; Shankland SJ
    J Am Soc Nephrol; 2016 Dec; 27(12):3611-3627. PubMed ID: 27080979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocytes as a target of prorenin in diabetes.
    Sakoda M; Itoh H; Ichihara A
    Curr Diabetes Rev; 2011 Jan; 7(1):17-21. PubMed ID: 21067509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin system within the diabetic podocyte.
    Márquez E; Riera M; Pascual J; Soler MJ
    Am J Physiol Renal Physiol; 2015 Jan; 308(1):F1-10. PubMed ID: 25339703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?
    Athyros VG; Mikhailidis DP; Kakafika AI; Tziomalos K; Karagiannis A
    Expert Opin Pharmacother; 2007 Apr; 8(5):529-35. PubMed ID: 17376010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.
    van den Hoven MJ; Waanders F; Rops AL; Kramer AB; van Goor H; Berden JH; Navis G; van der Vlag J
    Nephrol Dial Transplant; 2009 Sep; 24(9):2637-45. PubMed ID: 19429930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The (pro)renin receptor and the kidney.
    Ichihara A; Kaneshiro Y; Takemitsu T; Sakoda M; Itoh H
    Semin Nephrol; 2007 Sep; 27(5):524-8. PubMed ID: 17868789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the Renin-Angiotensin System Disrupts the Cytoskeletal Architecture of Human Urine-Derived Podocytes.
    Erichsen L; Thimm C; Bohndorf M; Rahman MS; Wruck W; Adjaye J
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the role of renin inhibition in the treatment of diabetic kidney disease?
    Komers R
    Curr Diab Rep; 2009 Dec; 9(6):447-52. PubMed ID: 19954690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The renin-angiotensin-aldosterone system and its suppression.
    Ames MK; Atkins CE; Pitt B
    J Vet Intern Med; 2019 Mar; 33(2):363-382. PubMed ID: 30806496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematical Model for Glucose Dependence of the Local Renin-Angiotensin System in Podocytes.
    Pilvankar MR; Higgins MA; Ford Versypt AN
    Bull Math Biol; 2018 Apr; 80(4):880-905. PubMed ID: 29520569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.